Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 2, 2002, Pages 589-598

  Feldman, Henry A ^a   Longcope, Christopher ^b   Derby, Carol A ^c   Johannes, Catherine B ^a   Araujo, Andre B ^a   Coviello, Andrea D ^b   Bremner, William J ^b   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANDROSTANOLONE; ESTRONE; GONADOTROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; COHORT ANALYSIS; FOLLOW UP; HEALTH STATUS; HUMAN; INFORMATION PROCESSING; LONGITUDINAL STUDY; MALE; MEASUREMENT; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL; UNITED STATES;

EID: 0036170745     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.2.8201     Document Type: Article

References (61)

1. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: Influence of application site
2. The endocrinology of aging
3. The influence of age, alcohol consumption, and body build on gonadal function in men
4. Longitudinal effects of aging on serum total and free testosterone levels in healthy men
5. Testicular endocrine function in the ageing male
6. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada
7. Predictors of sex hormone levels among the elderly: A study in Greece
8. Aging-related decline of gonadal function in healthy men: Correlation with body composition and lipoproteins
9. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study
10. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study
11. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
12. Age variation of the 24-hour mean plasma concentrations of androgens, estrogens, and gonadotropins in normal adult men
13. Aging in a 'healthy' population
14. Is there an epidemiologic basis for a male climacteric syndrome? The Massachusetts Male Aging Study
15. Impotence and its medical and psychosocial correlates in men aged 40-70: Results of the Massachusetts Male Aging Study
16. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: Prospective results from the Massachusetts Male Aging Study
17. A field approach for obtaining physiological measures in surveys of general populations: Response rates, reliability and costs
18. A profile instrument for the quantification and assessment of alcohol consumption
19. Height and weight tables
20. Does collecting repeated blood samples improve the precision of estimated steroid hormone levels?
21. Free estradiol, free testosterone, and sex hormone-binding globulin in perimenopausal women
22. Distribution and percentages of nonprotein bound contraceptive steroids in human serum
23. Steroid and gonadotropin levels in women during the peri-menopausual years
24. Estrone sulfate and dehydroepianderosterone sulfate concentrations in normal subjects and men with cirrhosis
25. An examination of research design effects on the association of testosterone and male aging
26. Loss of circadian rhythm in blood testosterone levels with aging in normal men
27. Error in the measurement of plasma free testosterone
28. Androgens in men: Uses and abuses
29. Hormonal changes and sexual function in aging men
30. The influence of aging on plasma sex hormones in men: The Telecom Study
31. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men
32. Longitundinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men: A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants
33. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
34. Clinical review 85: Emerging issues in androgen replacement therapy
35. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer
36. Prospective study of sex hormone levels and risk of prostate cancer
37. Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study
38. Androstanediol glucuronide in patients with pancreatic cancer or chronic pancreatitis
39. Potential activities of androgen metabolizing enzymes in human prostate
40. Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
41. Alteration of the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia
42. Dehydroepiandrosterone in treatment of erectile dysfunction: A prospective double-blind randomized placebo-controlled study
43. Longitudinal changes in dehydroepiandrosterone concentrations in men and women
44. DHEA and DHEA-S: A review
45. The epidemiology of DHEAS and cardiovascular disease
46. Recent insights into neuroendocrine mechanisms of aging of the human male hypothalamic-pituitary-gonadal axis
47. Influence of age on serum prolactin levels in women and men
48. Effect of age and sex on circulating and pituitary prolactin levels in human
49. Aging of the endocrine system
50. Serum prolactin and aging: Basal values and changes with estrogen use and hypothyroidism
51. Basal serum prolactin levels and prolactin responses to constant infusions of thyrotropin-releasing hormone in healthy aging men
52. Age alters pulsatile prolactin release: Influence of dopaminergic inhibition
53. The prolactin-secreting system in relation to aging
54. Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions
55. Prolactin and prolactin receptors are expressed and functioning in human prostate
56. A prospective, population-based study of androstenedione, estrogens and prostate cancer